AzTrials
AzTrials

AgingRePer-AGENCT07727369

RePer-AGE: Reorganization of Visuo-cognitive Functions Based on Peripheral Vision With Aging

A study testing Psychophysical visual recognition tasks, Ophthalmological assessment and Functional magnetic resonance imaging (fMRI) in people with Aging and Visual Perception, run by University Hospital, Grenoble at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The RePer-AGE study investigates how central and peripheral vision contribute to visual recognition and how these mechanisms change with normal aging. The study is based on the hypothesis that peripheral vision provides rapid global information that supports visual recognition through predictive mechanisms. Read more about this study

Who is it for?
Ages 18 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Aging, Visual Perception, Cognition
What is being tested?
Psychophysical visual recognition tasks, Ophthalmological assessment and Functional magnetic resonance imaging (fMRI)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
1 siteFrance
Study dates
1 Sep 2026to Sep 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy young adults aged 18 to 30 years or healthy older adults aged 60 to 85 years.
  • Normal or corrected-to-normal visual acuity.
  • No ophthalmological disease affecting visual function.
  • For participants aged 60 years or older: Mini-Mental State Examination (MMSE) score ≥23.
  • Affiliated with a national health insurance system.
  • Written informed consent.
Show all 12Show fewer
  • Non inclusion Criteria:
  • Individuals protected under French regulations governing research involving human participants.
  • Employees or individuals under the direct authority of the investigators.
  • History of neurological or psychiatric disorders likely to affect visual or cognitive functions.
  • Current treatment likely to alter visual function or vigilance.
  • MRI contraindications (metallic implants, pacemaker, severe claustrophobia, or other MRI safety contraindications) for participation in the MRI arm only.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site
  • CHU Grenoble Alpes

    Grenoble, Isère, 38043

    Carole Peyrin, PhD, 0033615351350, carole.peyrin@univ-grenoble-alpes.fr

    Mathilde Gallice, MD, 0033476767575, MGallice@chu-grenoble.fr

Other trials in France

About this study

The RePer-AGE study investigates how central and peripheral vision contribute to visual recognition and how these mechanisms change with normal aging. The study is based on the hypothesis that peripheral vision provides rapid global information that supports visual recognition through predictive mechanisms. Healthy young adults (18-30 years) and older adults (60-85 years) will undergo visual psychophysical testing, ophthalmological examinations, and, for a subset of participants, functional magnetic resonance imaging (fMRI). The results are expected to improve our understanding of age-related changes in visuo-cognitive functions and provide reference data for future studies on age-related visual disorders.

Read the detailed description

Visual recognition depends on the complementary contribution of central and peripheral vision. Central vision provides high spatial resolution and supports the detailed analysis required for object identification, whereas peripheral vision rapidly extracts coarse visual information that provides a global representation of the surrounding environment. According to predictive models of visual processing, this early peripheral information is used to generate predictions that facilitate the subsequent processing of detailed visual inputs.

The RePer-AGE project is based on the hypothesis that peripheral vision plays a key role in predictive visual processing and that this contribution changes during normal aging. Although aging is associated with well-documented declines in visual acuity and contrast sensitivity, particularly for high spatial frequencies, several findings suggest that the processing of coarse visual information conveyed by peripheral vision may be relatively preserved. This preserved processing may contribute to compensatory mechanisms supporting visual recognition in older adults.

RePer-AGE is a prospective, monocentric interventional study conducted at Grenoble Alpes University Hospital (CHU Grenoble Alpes) and the Laboratoire de Psychologie et NeuroCognition (LPNC, CNRS, Université Grenoble Alpes). The study will recruit 160 healthy volunteers divided into two age groups: young adults (18-30 years) and older adults (60-85 years). Participants will undergo an ophthalmological examination to ensure normal or corrected-to-normal vision and the absence of ocular disease likely to affect visual performance. Older participants will also complete a brief cognitive screening assessment.

The project combines complementary behavioral, ophthalmological, and neuroimaging approaches to investigate the respective contributions of central and peripheral vision to visual recognition.

The first research axis combines psychophysical experiments with ophthalmological assessments. Participants perform computerized visual recognition tasks specifically designed to evaluate the relative contribution of central and peripheral vision. Additional ophthalmological examinations include automated static perimetry to assess retinal sensitivity across the visual field and low-luminance visual acuity testing. These measurements will allow the relationship between retinal function and visual recognition performance to be investigated.

The second research axis combines psychophysical experiments with functional magnetic resonance imaging (fMRI). During MRI acquisition, participants perform visual recognition tasks while blood oxygen level-dependent (BOLD) activity is recorded. These data will be used to identify the cortical networks supporting predictive visual processing and to determine how these neural mechanisms are modified during normal aging.

The psychophysical paradigms are derived from previous studies conducted by the research team and investigate two complementary aspects of visual recognition. One paradigm evaluates the respective contribution of central and peripheral vision to scene categorization, whereas the second examines how semantic information extracted from peripheral vision influences the recognition of centrally presented visual stimuli through predictive mechanisms.

The primary objective of the study is to determine how central and peripheral vision differentially contribute to visual recognition and how these mechanisms are reorganized with aging. Secondary objectives include characterizing age-related changes in retinal sensitivity, examining the relationship between retinal function and behavioral performance, and identifying the neural correlates of predictive visual processing using functional MRI.

The results of RePer-AGE are expected to improve the understanding of the mechanisms underlying normal visual aging. They will provide normative reference data for future studies investigating pathological aging and visual disorders affecting central vision, and may ultimately contribute to the development of new approaches for visual assessment and rehabilitation.

Being tested
Psychophysical visual recognition tasks, Ophthalmological assessment, Functional magnetic resonance imaging (fMRI)
Keywords
Healthy Aging, Peripheral vision, Central vision, Visual recognition, Predictive processing, Psychophysics, Retinal sensitivity, fMRI

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Psychophysical visual recognition tasksBehavioural

    Computerized visual recognition tasks assessing the respective contributions of central and peripheral vision to scene recognition and predictive visual processing.

  • Ophthalmological assessmentDiagnostic test

    Ophthalmological examinations including retinal sensitivity (Humphrey automated perimetry) and low-luminance visual acuity.

  • Functional magnetic resonance imaging (fMRI)Diagnostic test

    Functional MRI performed during psychophysical visual recognition tasks to assess brain activity associated with visual recognition and predictive visual processing.

Study groups in NCT07727369
Study groupRoleWhat they receive
Psychophysics and OphthalmologyExperimentalParticipants undergo psychophysical visual recognition tasks together with ophthalmological examinations, including retinal sensitivity assessment by automated perimetry and low-luminance visual acuity testing.
Receives: Behavioral: Psychophysical visual recognition tasks; Diagnostic Test: Ophthalmological assessment
Psychophysics and Functional MRIExperimentalParticipants undergo psychophysical visual recognition tasks while functional magnetic resonance imaging (fMRI) is performed to investigate the neural mechanisms underlying visual recognition and predictive processing.
Receives: Behavioral: Psychophysical visual recognition tasks; Diagnostic Test: Functional magnetic resonance imaging (fMRI)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Behavioral performance during scene categorization tasks

    Behavioral performance will be assessed using accuracy and response time during computerized scene categorization tasks evaluating (1) central versus peripheral vision (EXC paradigm) and (2) semantic congruency between peripheral and central vision (VPC paradigm). Comparisons will be performed between young and older adults.

    Measured: Baseline (single experimental session)

Secondary outcomes (2)
  1. Retinal sensitivity

    Retinal sensitivity measured by Humphrey 30-2 automated perimetry, including Mean Deviation (MD), Pattern Standard Deviation (PSD), and retinal sensitivity thresholds.

    Measured: Baseline

  2. Brain activation during visual recognition

    Blood oxygen level-dependent (BOLD) activity measured by functional magnetic resonance imaging during scene categorization tasks, including whole-brain analyses and regions of interest involved in visual recognition and predictive processing.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2026
  2. Study start1 Sep 2026 (estimated)
  3. Primary completionMar 2030 (estimated)
  4. Study completionSep 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are assigned to one of two experimental arms according to the study procedures (psychophysics with ophthalmology or psychophysics with functional MRI). Both young and older adults are included in each arm.
Masking
None (open label)
Enrolment
160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07727369
Sponsor's protocol ID
38RC25.0395
Other IDs
ANR-25-CE28-6333, 2026-A00492-49
Acronym
RePer-AGE
Status last verified
Jul 2026
First submitted
21 Jul 2026
Last updated
27 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data necessary to reproduce the results reported in scientific publications will be shared. Data may include demographic, behavioral, ophthalmological, and neuroimaging data after anonymization, in accordance with the study Data Management Plan and applicable data protection regulations.

Publications

  • Faurite C, Aprile E, Kauffmann L, Mermillod M, Gallice M, Chiquet C, Cottereau BR, Peyrin C. Interaction between central and peripheral vision: Influence of distance and spatial frequencies. J Vis. 2024 Jan 2;24(1):3. doi: 10.1167/jov.24.1.3.

    PubMed 38190145
  • Peyrin C, Roux-Sibilon A, Trouilloud A, Khazaz S, Joly M, Pichat C, Boucart M, Krainik A, Kauffmann L. Semantic and Physical Properties of Peripheral Vision Are Used for Scene Categorization in Central Vision. J Cogn Neurosci. 2021 Apr 1;33(5):799-813. doi: 10.1162/jocn_a_01689.

    PubMed 34449843
  • Trouilloud A, Kauffmann L, Roux-Sibilon A, Rossel P, Boucart M, Mermillod M, Peyrin C. Rapid scene categorization: From coarse peripheral vision to fine central vision. Vision Res. 2020 May;170:60-72. doi: 10.1016/j.visres.2020.02.008. Epub 2020 Apr 4.

    PubMed 32259648
  • Roux-Sibilon A, Peyrin C, Greenwood JA, Goffaux V. Radial bias in face identification. Proc Biol Sci. 2023 Jun 28;290(2001):20231118. doi: 10.1098/rspb.2023.1118. Epub 2023 Jun 28.

    PubMed 37357864

Questions about this trial

What is this clinical trial studying?

A study testing Psychophysical visual recognition tasks, Ophthalmological assessment and Functional magnetic resonance imaging (fMRI) in people with Aging and Visual Perception, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 27 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Carole Peyrin, PhD (0033615351350, carole.peyrin@univ-grenoble-alpes.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Behavioral performance during scene categorization tasks (time frame: Baseline (single experimental session)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07727369, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in